CR 250 > Pill - white round, 11mm
Pill with imprint CR 250 > is White, Round and has been identified as Ciprofloxacin Hydrochloride 250 mg. It is supplied by Cobalt Laboratories Inc.
Ciprofloxacin is used in the treatment of Bacterial Infection; Bacteremia; Anthrax; Anthrax Prophylaxis; Typhoid Fever and belongs to the drug class quinolones and fluoroquinolones. Risk cannot be ruled out during pregnancy. Ciprofloxacin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CR 250 >
Ciprofloxacin Hydrochloride
- Imprint
- CR 250 >
- Strength
- 250 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Quinolones and fluoroquinolones
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cobalt Laboratories Inc
- Inactive Ingredients
-
corn starch,
crospovidone,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
water,
silicon dioxide,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 16252-0514 | Cobalt Laboratories, Inc. |
| 68084-0069 (Discontinued) | Amerisource Health Services |
Related images for "CR 250 >"
More about ciprofloxacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (927)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: quinolones and fluoroquinolones
- Breastfeeding
Patient resources
- Ciprofloxacin drug information
- Ciprofloxacin injection
- Ciprofloxacin (Intravenous) (Advanced Reading)
- Ciprofloxacin (Oral) (Advanced Reading)
- Ciprofloxacin Extended-Release Tablets
Other brands
Professional resources
- Ciprofloxacin monograph
- Cipro IV (FDA)
- Ciprofloxacin (FDA)
- Ciprofloxacin Extended Release Tablets (FDA)
- Ciprofloxacin Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
